Login / Signup
Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus.
Keisuke Maeshima
Hirotaka Shibata
Published in:
Annals of the rheumatic diseases (2020)
Keyphrases
</>
systemic lupus erythematosus
disease activity
low grade
rheumatoid arthritis
high grade